small intestinal submucosa: a substrate for in vitro cell growth
TRANSCRIPT
This article was downloaded by: [Laurentian University]On: 06 December 2014, At: 15:40Publisher: Taylor & FrancisInforma Ltd Registered in England and Wales Registered Number: 1072954Registered office: Mortimer House, 37-41 Mortimer Street, London W1T 3JH, UK
Journal of Biomaterials Science,Polymer EditionPublication details, including instructions for authors andsubscription information:http://www.tandfonline.com/loi/tbsp20
Small intestinal submucosa: asubstrate for in vitro cell growthStephen F. Badylak a , Rae Record b , Kristina Lindberg c ,Jason Hodde d & Kinam Park ea Hillenbrand Biomedical Engineering Center, PurdueUniversity, A. A. Potter Bldg., West Lafayette, IN 47907,USAb Hillenbrand Biomedical Engineering Center, PurdueUniversity, A. A. Potter Bldg., West Lafayette, IN 47907,USAc Hillenbrand Biomedical Engineering Center, PurdueUniversity, A. A. Potter Bldg., West Lafayette, IN 47907,USAd Hillenbrand Biomedical Engineering Center, PurdueUniversity, A. A. Potter Bldg., West Lafayette, IN 47907,USAe Industrial and Physical Pharmacy, Purdue University,Robert Heine Pharmacy Bldg., West Lafayette, IN 47907,USAPublished online: 02 Apr 2012.
To cite this article: Stephen F. Badylak , Rae Record , Kristina Lindberg , Jason Hodde &Kinam Park (1998) Small intestinal submucosa: a substrate for in vitro cell growth, Journalof Biomaterials Science, Polymer Edition, 9:8, 863-878, DOI: 10.1163/156856298X00208
To link to this article: http://dx.doi.org/10.1163/156856298X00208
PLEASE SCROLL DOWN FOR ARTICLE
Taylor & Francis makes every effort to ensure the accuracy of all the information(the “Content”) contained in the publications on our platform. However, Taylor& Francis, our agents, and our licensors make no representations or warrantieswhatsoever as to the accuracy, completeness, or suitability for any purposeof the Content. Any opinions and views expressed in this publication are theopinions and views of the authors, and are not the views of or endorsed by Taylor
& Francis. The accuracy of the Content should not be relied upon and should beindependently verified with primary sources of information. Taylor and Francisshall not be liable for any losses, actions, claims, proceedings, demands, costs,expenses, damages, and other liabilities whatsoever or howsoever caused arisingdirectly or indirectly in connection with, in relation to or arising out of the use ofthe Content.
This article may be used for research, teaching, and private study purposes.Any substantial or systematic reproduction, redistribution, reselling, loan,sub-licensing, systematic supply, or distribution in any form to anyone isexpressly forbidden. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions
Dow
nloa
ded
by [
Lau
rent
ian
Uni
vers
ity]
at 1
5:40
06
Dec
embe
r 20
14
Small intestinal submucosa: a substrate for in vitro
cell growth
STEPHEN F. BADYLAK 1,*, RAE RECORD1, KRISTINA LINDBERG1, JASON HODDE1 and KINAM PARK 2
1Hillenbrand Biomedical Engineering Center, Purdue University, A. A. Potter Bldg., West Lafayette, IN 47907, USA
2 Industrial and Physical Pharmacy, Purdue University, Robert Heine Pharmacy Bldg., West Lafayette, IN 47907, USA
Received 22 November 1997; accepted 9 February 1998
Abstraet-The extracellular matrix (ECM) of the small intestinal submucosa (SIS) was harvested by removing the superficial layers of the mucosa and the external muscular layers. The remaining 80 µm thick sheet was disinfected and sterilized by methods which removed all cellular components. The SIS-ECM, retaining its native 3-dimensional microarchitecture and composition, was evaluated for its
ability to support in vitro cell growth. Six separate cell types were seeded either alone or in coculture with other cells upon this matrix, grown in selected media, and examined daily for time periods ranging from 48 h to 2 weeks. The six cell types tested were NIH Swiss mouse 3T3 fibroblasts, NIH 3T3/J2 fibroblasts, primary human fibroblasts, primary human keratinocytes, human microvascular endothelial cells (HMECs), and an established rat osteosarcoma (ROS) cell line. All cell types showed the ability to attach and proliferate. All fibroblast cell lines and the keratinocytes proliferated and/or
migrated into the 3-dimensional scaffold of the SIS matrix. The ROS cells and the HMECs were confined in their growth pattern to the surface of the matrix. Coculturing of NIH 3T3/J2 fibroblasts and primary human keratinocytes resulted in a distinctive spatial orientation of the two cell types. The fibroblasts populated the mid-substance of the 3-dimensional matrix and the keratinocytes formed an
epidermal structure with rete ridge-like formation and stratification when the composite was lifted to an air liquid interface in culture. In summary, SIS provides a substratum with a 3-dimensional scaffold that allows for cell migration and spatial organization. This substratum is suitable for in vitro studies of the interaction between epithelial or mesenchymal cells and a naturally occurring extracellular matrix.
Key words: Small intestinal submucosa; cell culture; in vitro cell growth; cell growth substrate; substratum; extracellular matrix.
Dow
nloa
ded
by [
Lau
rent
ian
Uni
vers
ity]
at 1
5:40
06
Dec
embe
r 20
14
864
INTRODUCTION
The attachment, growth, and differentiation of cells in vitro is critically dependent
upon the composition of the growth substrates within the culture media and within
the substratum upon which the cells are grown. Components of the in vivo
extracellular matrix (ECM) such as fibronectin, collagen, glycosaminoglycans,
hyaluronic acid, and fibrinogen have been purified and combined in various ways that are suitable for the growth of various cell types. Three-dimensional matrices
have also been developed which allow for the in vitro growth of cells not only on
the surface of the matrix but also within the matrix itself [l, 2]. A three-dimensional
substratum permits the migration and spatial orientation of cells in a manner which
theoretically more closely mimics the in vivo setting. Scaffolds which are derived
from naturally occurring ECMs and which have been used as cell culture substrates
include amnionic membrane [3], lens capsule [4], and basement membrane extracts
derived from Engelbreth Holm Swarm tumor (Matrigel). These matrices provide an
alternative substratum for cell growth and differentiation compared to the plastic cell
culture dish; however, their use has been limited by problems related to sterilization,
manufacturing, and availability. The field of tissue engineering has recently identified several biomaterials suitable
for use as tissue scaffolds. The materials are both synthetic and biologic in
nature, upon which cells are grown for the purpose of reconstituting or replacing various body parts. One such scaffold, derived from the submucosa and basilar
mucosal layers of the small intestine (SIS), has been shown to have properties which promote tissue remodeling in numerous body locations including the lower
urinary tract [5-7], dermis and epidermis [8], tendon and ligament [9, 10], body wall [11], and blood contact surfaces such as small and large diameter arteries
and veins [12-15]. This naturally occurring ECM consists of approximately 90%
collagen (mainly Type I), fibronectin [16], five different glycosaminoglycans [17],
growth factors such as TGFB and basic FGF [18], and various proteoglycans and
glycoproteins. The complex composition of SIS has been retained in its native
3-dimensional form for in vivo applications. Within 2-3 months of in vivo
grafting, the SIS scaffold is typically replaced by a host derived neomatrix with
cellular components which include fibroblasts, endothelial cells, and epithelial cells
appropriate for the recipient tissue. It is plausible therefore that the SIS biomaterial, with its natural 3-dimensional architecture would be useful for the evaluation of the
interaction between various cell types and the ECM in vitro. In the present study we evaluated the mode of growth of six separate cell types upon SIS in vitro.
MATERIALS AND METHODS
Preparation of'SIS
SIS was prepared from the jejunum of pigs weighing between 110 and 120 kg
according to methods previously reported [12-16]. In brief, intestines were
Dow
nloa
ded
by [
Lau
rent
ian
Uni
vers
ity]
at 1
5:40
06
Dec
embe
r 20
14
865
collected immediately following euthanasia of the animals, rinsed free of contents
with water, and the superficial mucosal layers and external muscular layers were
removed by mechanical delamination. The remaining trilaminate tube structure
consisted of the submucosa, muscularis mucosa and basilar layers of the mucosa
(also called stratum compactum). This tube was split longitudinally creating a sheet
which was subsequently rinsed with water to lyse any remaining cells associated
with the matrix and rid the material of any cellular debris. A sheet of SIS was
oriented based upon identification of the stratum compactum surface. The opposite side of the SIS sheet was referred to as the abluminal surface. The tissue was then
disinfected with 0. I % peracetic acid in 20% ethanol followed by treatment with
1.5 MRad gamma irradiation. The sheets of SIS were then cut into appropriate size
and shaped to fit the tissue culture vessel.
Cell types grown on SIS
The following cell types were grown on sheets of SIS: Primary human fibroblasts
derived from a skin biopsy obtained from a clinically normal 42 year old woman
undergoing plastic surgery; NIH 3T3/J2 fibroblasts, a gift from Howard Green, Harvard Medical School, Boston, MA, USA; NIH Swiss 3T3 mouse fibroblasts, American type culture collection (ATTC) Rockville, MD; Human microvascular
endothelial cells (HMEC-1), a gift from Francisco Candal and colleagues at the
National Center for Infectious Diseases at the Center for Disease Control, Atlanta,
GA, USA; an established osteosarcoma cell line (ROS 17/2.8), a gift from Gregg Wesolowski at Merek, Sharp & Dohme Research Laboratories, West Point, PA,
USA; and primary cultures of human epidermal keratinocytes derived from a skin
biopsy obtained from a clinically normal 20 year old male.
Tissue culture conditions
The cell types and medium conditions used are described in Table 1.
Coculture of 3T3/J2 fibroblasts and primary human keratinocytes. Swiss mouse
NIH 3T3 /J2 were seeded at 5 x 106 cells cm-2 on the abluminal surface of NIH 3T3/J2 were seeded at 5 x 10? cells on the abluminal surface of
SIS. The fibroblasts on SIS were cultivated in Dulbecco's minimal essential
medium (DMEM) supplemented with 10% bovine calf serum (Hyclone, Logan, UT, USA) for 2-3 days prior to adding human epidermal keratinocytes to the
stratum compactum surface of SIS. The keratinocyte population was expanded in
the secondary or third passage using the Rheinwald and Green technique based on
cocultivation of Swiss mouse NIH 3T3/J2 cells and keratinocytes [19, 20]. The
tissue culture vessels were pre-plated with gamma-irradiated (6000 Rad) 3T3/J2-
fibroblast feeder cells (2.7 x 104 cells cm-2). The keratinocytes were seeded at
5 x 104 cells per 75 cm2 flask or at 0.5 x 106 cells per 75 cm2 flask (Corning Costar,
NY, USA) and grown in a 3 : 1 mixture of DMEM and Ham's F12 media (Sigma Chemical Co., St. Louis, MO, USA), supplemented with 10% fetal calf serum
Dow
nloa
ded
by [
Lau
rent
ian
Uni
vers
ity]
at 1
5:40
06
Dec
embe
r 20
14
866
Table 1.
Summary of cell types and medium used
Cell type Medium'
Human DMEM and Ham's F12 media
epidermal 3 : 1 supplemented with 10% fetal
keratinocytes calf serum, 0.4 ng ml - 1
hydrocortisone, 10 f.1g ml-l human
epidermal growth, 10 IIM cholera toxin, 5 f.1g ml-l Zn-free
insulin, 24 f.1 g ml-1 adenine, 2 x 10-9 M 3,3',5-triiodo-L-thyronine
Human DMEM supplemented with 10% fibroblasts bovine calf serum
Swiss mouse DMEM supplemented with 10% NIH 3T3 neonatal calf serum fibroblasts
Swiss mouse DMEM supplemented with 10% NIH 3T3/12 bovine calf serum fibroblasts
Human MCDB 131 supplemented with microvascular 10% fetal bovine serum, 1 ng ml-l endothelial cells epidermal growth factor (EGF), (HMEC) and 1 /lg ml-1 hydrocortisone
Rat osteo- Ham's F-12 supplemented with sarcoma cells 28 mM HEPES and 1.1 mum
(ROS 17/2.8) Ca2+ and 5% fetal bovine serum
G 5000 U penicillin/5000 ttg streptomycin was added to all media.
(Hyclone, Logan, UT), hydrocortisone (Sigma Chemical Co., St. Louis,
MO, USA), 10 ng ml-l human epidermal growth factor (Austral Biologicals, San
Ramon, CA, USA), 10-1° M cholera toxin (Sigma Chemical Co., St. Louis,
MO, USA), 5 ,?g ml-1 Zn-free insulin (a gift from Lilly Research Laboratories,
Indianapolis, IN, USA), 24 ttgml-l adenine (Sigma Chemical Co., St. Louis,
MO, USA), and 2 x 10-9 M 3,3',5-triiodo-L-thyronine (Sigma Chemical Co., St.
Louis, MO, USA). After 6-7 days, preconfluent primary keratinocyte cultures were
incubated briefly with a 0.02% EDTA solution to remove the feeder cells. The
keratinocyte colonies were then dissociated into single cells by incubating the cells
with 0.05% trypsin and 0.01% EDTA PBS buffered solution and were subcultured
onto the stratum compactum surface of SIS at a density of 5 x 106 cells cm-2 SIS.
The NIH 3T3/J2 fibroblasts/keratinocyte/SIS composite was grown submerged in medium for 2-3 days, then lifted to the air-liquid interface. Alternatively, the keratinocytes seeded at the higher density which had reached confluence after
6-7 days were released as a cohesive sheet of cells by incubating the culture
Dow
nloa
ded
by [
Lau
rent
ian
Uni
vers
ity]
at 1
5:40
06
Dec
embe
r 20
14
867
for 30-40 min in 2.5 mg ml-1 Dispase II (Boeringer-Mannheim, USA). The cell
sheet was mounted on a petroleum gauze support, 'transplanted' onto the stratum
compactum surface of SIS, and placed at the air-liquid interface. The composites
consisting of fibroblasts and keratinocytes on SIS were grown for 48 h, 5 days or
one week.
NIH Swiss mouse 3T3 fibroblasts and primary human fibroblasts. The NIH
Swiss mouse 3T3 fibroblasts and the human primary fibroblasts were maintained
in DMEM media supplemented with 10% neonatal calf serum and 10% bovine calf
serum, respectively. The fibroblasts were seeded on the abluminal surface or on the
luminal surface of SIS at 5 x 105 cells CM-2 SIS and grown for 48 h, 72 h, or for
2 weeks.
Human microvascular endothelial cells. HMEC cells were grown in MCDB 131 1
(Life Technologies) supplemented to contain 10% fetal bovine serum, 1 ng ml-1
epidermal growth factor (EGF), and 1 /-tgml-l hydrocortisone. The HMEC cells
were seeded on the abluminal surface or on the stratum compactum surface of SIS
at 5 x 105 cells cm-2 SIS and grown for 48 h, 72 h, or for 2 weeks.
Rat osteosarcoma cells. Rat osteosarcoma (ROS 17/2.8) cells ROS cells were
maintained in Ham's F-12 media modified to contain 28 mM HEPES and 1.1 mlvl
Ca 2+ and supplemented to contain 5% fetal bovine serum. The ROS cells were
seeded on the abluminal surface or on the stratum compactum surface of SIS at
5 x 105 cells cm-2 SIS and grown for 48 h, 72 h, or for 2 weeks.
Histological evaluation
The composites consisting of the various cell types on SIS were fixed in 10% neutral
buffered formalin at the time points stated above and embedded in paraffin. The
composites were then sectioned, stained with Hematoxylin and Eosin (H & E), and
evaluated using light microscopy.
RESULTS
Human epidermal keratinocytes cocultured with NIH 3T3/J2 fibroblasts
Human epidermal keratinocytes seeded as single cells (Figs 1 and 2) or 'trans-
planted' as a cohesive sheet of stratified keratinocytes onto the stratum compactum side of SIS (Fig. 3) showed attachment and changes in cell morphology. After 48 h
in culture the keratinocytes seeded as single cells had formed a monolayer (Fig. 1), and the basal cells of the cell sheet that had been 'transplanted' onto SIS were at-
tached to the substrate (not illustrated). By days 5 and 7 the upper strata of the
'transplant', which is up to six cell layers thick, had stratified and the disorganized
Dow
nloa
ded
by [
Lau
rent
ian
Uni
vers
ity]
at 1
5:40
06
Dec
embe
r 20
14
868
Dow
nloa
ded
by [
Lau
rent
ian
Uni
vers
ity]
at 1
5:40
06
Dec
embe
r 20
14
869
Dow
nloa
ded
by [
Lau
rent
ian
Uni
vers
ity]
at 1
5:40
06
Dec
embe
r 20
14
870
Dow
nloa
ded
by [
Lau
rent
ian
Uni
vers
ity]
at 1
5:40
06
Dec
embe
r 20
14
871
cell sheet had terminally differentiated, forming a stratum comeum-like structure
(Fig. 3). At days 5 and 7 the epithelial-like structure, which was formed from the
keratinocytes seeded as single cells and the cell sheet that had been 'transplanted' onto SIS, consisted of a three to six cell layer thick stratified epithelium. The basal
cells tended to migrate into the SIS in a rete ridge-like pattern (Figs 2 and 3).
Human fibroblasts and NIH 3T3 fibroblasts
The three types of fibroblasts tended to form monolayers on the stratum compactum side of SIS. After 48 h in culture the fibroblasts seeded onto the abluminal surface
of SIS showed early migration into the substrate (Figs 4 and 5). Invasion into the
deeper layers of SIS usually did not occur before 72 h. By day 7, the fibroblasts
were often distributed throughout the 80 itm thickness of the SIS substrate (Fig. 5). The human fibroblasts showed an elongate, spindle shaped morphology consistent
with the usual morphological feature of fibroblasts. The NIH 3T3 fibroblasts were
larger and more plump than the human fibroblhsts. The cells remained elongate with
a centrally placed round oval nucleus. Cells could be found in both small clusters
as well as single cells which had migrated into adjacent areas of the substratum.
Human microvascular endothelial cells
The HMEC cells (Fig. 6) formed a monolayer at all time points studied. These cells
did not invade the SIS substratum when placed on either the stratum compactum surface or the abluminal surface. The HMECs maintained a spindle shaped
morphology with a centrally placed oval nucleus. There was no evidence for tube
formation.
Rat osteosarcoma cells
The ROS cells proliferated and showed changes in morphology when placed on
the SIS material (Fig. 7). The cells remained confined to the surface of the SIS
sheets regardless of whether they were seeded onto the stratum compactum or
the abluminal side of the SIS. The ROS cells grew in polylayers of three to six
cells thick. Small clumps of cells formed layers as thick as eight to ten cells.
The most superficial layers of the ROS cells showed a change in morphology. These superficial cells tended to become larger, occasionally multinucleated and
these cells contained vacuoles within their cytoplasm. In addition, there was
the appearance of an eosinophilic staining matrix around some of the cells in
both the superficial layers of the SIS and at the stratum compactum surface after
approximately 7 days.
DISCUSSION
This study demonstrates the utility of a naturally occurring extracellular matrix derived from the small intestine of pigs as a substratum for in vitro cell growth. Six
Dow
nloa
ded
by [
Lau
rent
ian
Uni
vers
ity]
at 1
5:40
06
Dec
embe
r 20
14
872
Dow
nloa
ded
by [
Lau
rent
ian
Uni
vers
ity]
at 1
5:40
06
Dec
embe
r 20
14
873
Dow
nloa
ded
by [
Lau
rent
ian
Uni
vers
ity]
at 1
5:40
06
Dec
embe
r 20
14
874
Dow
nloa
ded
by [
Lau
rent
ian
Uni
vers
ity]
at 1
5:40
06
Dec
embe
r 20
14
875
Dow
nloa
ded
by [
Lau
rent
ian
Uni
vers
ity]
at 1
5:40
06
Dec
embe
r 20
14
876
separate cell types of mesenchymal and epithelial origin showed variable patterns of growth both on the surface and within the midsubstance of this substratum.
The advantages of SIS for in vitro cell growth include a composition and a
microarchitecture which is conducive to cell growth and allows for cell migration in
three dimensions. The composition and structure of SIS contrast markedly with
the majority of in vitro culture substrates upon which cells are grown in which
only two dimensional growth is possible. These two-dimensional systems usually involve an artificial substratum of plastic or glass. For example, cells have been
successfully grown on polyvinyl chloride, polycarbonate, polytetrafluoroethylene, melinex, and thermanox. Cells cultured upon these artificial substrates therefore
acquire their nutrition and signals for growth and differentiation almost entirely from the media in which they are grown and microenvironmental conditions such
as C02 concentration, barometric pressure, and temperature. In contrast, the SIS
substratum provides numerous structural characteristics which represent the native
environment encountered in vivo. Although it has been shown that SIS is rich in
growth factors, glycosaminoglycans and other potential nutrients for cell growth, the methods by which the present study were conducted with complete media makes
it impossible to determine the extent to which the composition of the SIS substratum
itself contributed to cell proliferation and differentiation. One limitation of the use
of the sheet form of SIS for in vitro cell culture is the inability to visualize the cells
due to the density of the substrate. Fixation of the substrate with attached cells and
subsequent sectioning and staining is necessary to obtain information regarding the
pattern of cell growth and/or degree of differentiation.
By providing a naturally occurring ECM such as SIS for in vitro cell culture, it is plausible that a pattern or mode of cell growth will more closely mimic the
in vivo behavior of such cells. For example, all three types of fibroblasts which
were evaluated grew throughout the entire thickness of the SIS matrix. The ROS
cells confined their growth to the surface but formed polylayers which maintained
distinctive phenotypic characteristics even in the most superficial cells. ROS cells, a
transformed osteoblast cell line, grow in a pattern reminiscent of osteoblasts in vivo
whereby new bone formation is laid down on the surface of existing bone and
connective tissue, similar to the cell growth pattern observed on SIS. Similarly, the pattern of keratinocyte growth into the underlying SIS substratum in the present
study is similar to the rete ridge formation which occurs in normal epidermis. The
major difference between the in vitro microenvironment with SIS and the in vivo
environment is the source of nutrition. In vivo, blood vessels would be supplying the substrates and nutrients for cell growth and differentiation whereby in vitro the
source of nutrition is provided by the media and/or substratum.
The biologic origin of SIS and its function in vivo likely contributes to its
utility as an in vitro substrate for cell growth. The complex composition of this
naturally occurring extracellular matrix is largely responsible for the in vivo signals which cause cell attachment, migration, proliferation, and differentiation. In vivo, the submucosa and basilar layers of the mucosa support a rapidly dividing cell
Dow
nloa
ded
by [
Lau
rent
ian
Uni
vers
ity]
at 1
5:40
06
Dec
embe
r 20
14
877
population, the small intestine enterocytes. In addition, this layer is repeatedly
subjected to the insults originating in the intestinal lumen including infectious
agents, mechanical trauma, and digestive juices which occasionally breach the
mucosal barrier. Therefore, it is plausible that the extracellular matrix in this
location has developed a very suitable composition and structure for rapid cell
growth and differentiation (i.e. repair and regeneration). In summary, we report the utility of a naturally occurring extracellular matrix
derived from porcine small intestine for in vitro cell growth. This matrix provides a plethora of structural and functional proteins which are arranged in a three-
dimensional architecture which is suitable for examining cell growth patterns in vitro. The substrate is limited by its inability to permit visualization of cells
in vitro but offers a three-dimensional microarchitecture for cells to grow in a
more natural spatial arrangement than is possible with traditional two-dimensional
culture systems. SIS provides a complement to existing substrates for in vitro cell
growth, and may find utility in research laboratories where interest in cell-matrix
interactions exist.
Acknowledgements
The authors would like to acknowledge the technical assistance of Stephanie Hill,
Cheryl Haines, and Cheryl Holdman.
REFERENCES
1. J. Leighton, In Vitro Cell. Dev. Biol. 27A, 786 (1991). 2. W. H. Douglas, J. A. McAteer, R. T. Dell'Orco and D. Phelps, In Vitro Cell. Dev. Biol. 16, 306
(1980). 3. L. A. Liotta, C. W. Lee and D. J. Morakis, Cancer Lett. 11, 141 (1980). 4. P. Dehm and N. A. Kefalides, J. Biol. Chem. 253, 6680 (1978). 5. P. M. Knapp, J. E. Lingeman, Y. I. Siegel, S. F. Badylak and R. J. Demeter, J. Endourol. 8, 125
(1994). 6. B. P. Kropp, B. L. Eppley, C. D. Prevel, M. K. Rippy, R. C. Harruff, S. F. Badylak, M. C. Adams,
R. C. Rink and M. A. Keating, Urology 46, 396 (1995). 7. B. P. Kropp, M. K. Rippy, S. F. Badylak, M. C. Adams, M. A. Keating, R. C. Rink and K. B. Thor,
J. Urol. (in press). 8. C. D. Prevel, B. L. Eppley, D. J. Summerlin, J. R. Jackson, M. McCarty and S. F. Badylak,
J. Plast. Surg. 35, 381 (1995). 9. J. P. Hodde, S. F. Badylak and K. D. Shelbourne, Tissue Eng. 3, 27 (1997).
10. S. W. Aiken, S. F. Badylak, J. P. Toombs, K. D. Shelbourne, M. C. Hiles, G. C. Lantz and D. Van
Sickle, Vet. Comp. Orthopedics Traumatol. 7, 124 (1994). 11. C. D. Prevel, B. L. Eppley, D. J. Summerlin, J. R. Jackson, M. McCarty and S. F. Badylak, Ann.
Plast. Surg. 35, 374 (1995). 12. M. C. Hiles, S. F. Badylak, G. C. Lantz, L. A. Geddes, K. Kokini and R. J. Morff, J. Biomed.
Mater. Res. 29, 883 (1995). 13. G. C. Lantz, S. F. Badylak, G. E. Sandusky, M. C. Hiles, A. C. Coffey, L. A. Geddes and
K. Kokini, J. Invest. Surg. 6, 297 (1993).
Dow
nloa
ded
by [
Lau
rent
ian
Uni
vers
ity]
at 1
5:40
06
Dec
embe
r 20
14
878
14. G. E. Sandusky, G. C. Lantz and S. F. Badylak, J. Surg. Res. 58, 415 (1995). 15. G. C. Lantz, S. F. Badylak, A. C. Coffey, L. A. Geddes and G. E. Sandusky, J. Surg. Res. 53, 175
(1992). 16. T. B. McPherson and S. F. Badylak, Tissue Eng. (in press). 17. J. P. Hodde, S. F. Badylak, A. O. Brightman and S. L. Voytik-Harbin, Tissue Eng. 2, 209 (1996). 18. S. L. Voytik-Harbin, A. O. Brightman, B. Waisner, C. Lamar and S. F. Badylak, J. Cell Biol.
(in press). 19. J. G. Rheinwald and H. Green, Cell 6, 331 (1975). 20. J. G. Rheinwald, in: Cell growth and Division. A Practical Approach, R. Basega (Ed.), p. 81.
IRL Press, Oxford (1989).
Dow
nloa
ded
by [
Lau
rent
ian
Uni
vers
ity]
at 1
5:40
06
Dec
embe
r 20
14